Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-1216-2015

Drug recall · July 15, 2015

Bupivacaine Hydrochloride Inj recall

Why: Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials, Rx only. HOSPIRA, INC., LAKE FOREST, IL 60045 USA. NDC: 0409-1162-02.

Lots / codes

Lot #: 38-515-DK, Expiry: 1 FEB 2016.

Quantity
150,950 Vials
Company
Hospira Inc., Lake Forest, IL
Distribution
U.S. Nationwide including Guam.
Initiated
April 23, 2015 · Voluntary: Firm initiated
Classified
July 8, 2015
Reported
July 15, 2015
Ended
January 26, 2016
How notified
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Bupivacaine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.